Stephen Lane
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cutaneous Melanoma Detection and Management
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 20
- Lung Cancer Research Studies 15
-
- Cancer therapeutics and mechanisms 10
- Melanoma and MAPK Pathways 5
- Co-authors
- Scott Z. Fields (5 shared papers)Graham Ross (2 shared papers)Joachim von Pawel (2 shared papers)G. Ross (6 shared papers)A Depierre (1 shared paper)Joan H. Schiller (1 shared paper)Martin Palmer (1 shared paper)Peter Clark (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (3 papers)British Journal of Cancer (2 papers)Clinical Lung Cancer (2 papers)The Lancet Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Stephen Lane
30 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 1.4k
- Epidemiology 730
- Reproductive Medicine 176
- Molecular Biology 934
- Pulmonary and Respiratory Medicine 344
Countries citing papers authored by Stephen Lane
This map shows the geographic impact of Stephen Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Lane more than expected).
Fields of papers citing papers by Stephen Lane
This network shows the impact of papers produced by Stephen Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Lane. The network helps show where Stephen Lane may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Lane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer Hit paper breakdown → | 1999 | 694 |
| 2 | 2016 | 212 | |
| 3 | 2001 | 175 | |
| 4 | 2011 | 126 | |
| 5 | 2003 | 86 | |
| 6 | 1999 | 60 | |
| 7 | 2016 | 52 | |
| 8 | 2016 | 48 | |
| 9 | 2009 | 47 | |
| 10 | 2001 | 41 | |
| 11 | 2004 | 36 | |
| 12 | 2004 | 30 | |
| 13 | 2010 | 29 | |
| 14 | 2011 | 26 | |
| 15 | 2005 | 26 | |
| 16 | 2015 | 19 | |
| 17 | 2001 | 12 | |
| 18 | 2005 | 12 | |
| 19 | 2000 | 10 | |
| 20 | 2010 | 6 |
About Stephen Lane
Stephen Lane is a scholar working on Oncology, Molecular Biology, Reproductive Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (15 papers), Cancer therapeutics and mechanisms (10 papers), Ovarian cancer diagnosis and treatment (9 papers), Neuroendocrine Tumor Research Advances (7 papers), Melanoma and MAPK Pathways (5 papers), Lung Cancer Treatments and Mutations (5 papers), Nausea and vomiting management (4 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). The work is most often cited by research in Oncology (1.4k citations), Epidemiology (730 citations), Reproductive Medicine (176 citations), Molecular Biology (934 citations) and Pulmonary and Respiratory Medicine (344 citations). Stephen Lane has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Scott Z. Fields, Graham Ross, Joachim von Pawel, G. Ross, A Depierre, Joan H. Schiller, Martin Palmer, Peter Clark, J P Kleisbauer and Richard J. Gralla. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Clinical Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.